Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank43
3Y CAGR-20.7%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-20.7%/yr
vs +181.7%/yr prior
Acceleration
-202.4pp
Decelerating
Percentile
P43
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$156.97M-24.8%
2024$208.73M-21.3%
2023$265.35M-15.7%
2022$314.92M-13.4%
2021$363.58M+1323.3%
2020$-29.72M-264.6%
2019$18.05M+261.0%
2018$5.00M-